WO2011081445A3 - 에틸아미노 벤조산 유도체의 치료 용도 - Google Patents
에틸아미노 벤조산 유도체의 치료 용도 Download PDFInfo
- Publication number
- WO2011081445A3 WO2011081445A3 PCT/KR2010/009498 KR2010009498W WO2011081445A3 WO 2011081445 A3 WO2011081445 A3 WO 2011081445A3 KR 2010009498 W KR2010009498 W KR 2010009498W WO 2011081445 A3 WO2011081445 A3 WO 2011081445A3
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- benzoic acid
- acid derivatives
- treatment use
- ethylamino
- ethylamino benzoic
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
- A61K31/136—Amines having aromatic rings, e.g. ketamine, nortriptyline having the amino group directly attached to the aromatic ring, e.g. benzeneamine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
- A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
- A61K31/216—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acids having aromatic rings, e.g. benactizyne, clofibrate
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2121/00—Preparations for use in therapy
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Emergency Medicine (AREA)
- Nutrition Science (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Physiology (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Abstract
본 발명은 에틸아미노 벤조산 유도체 또는 이의 약학적으로 허용가능한 염의 신규 의약 용도에 관한 것이다.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1020090132403A KR101646701B1 (ko) | 2009-12-29 | 2009-12-29 | 에틸아미노 벤조산 유도체의 치료 용도 |
KR10-2009-0132403 | 2009-12-29 |
Publications (2)
Publication Number | Publication Date |
---|---|
WO2011081445A2 WO2011081445A2 (ko) | 2011-07-07 |
WO2011081445A3 true WO2011081445A3 (ko) | 2011-11-10 |
Family
ID=44227042
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/KR2010/009498 WO2011081445A2 (ko) | 2009-12-29 | 2010-12-29 | 에틸아미노 벤조산 유도체의 치료 용도 |
Country Status (2)
Country | Link |
---|---|
KR (1) | KR101646701B1 (ko) |
WO (1) | WO2011081445A2 (ko) |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR20210107828A (ko) * | 2018-12-28 | 2021-09-01 | 주식회사 지엔티파마 | 신경퇴행성 질환 치료를 위한 조성물 및 방법 |
CN112479912A (zh) * | 2020-12-08 | 2021-03-12 | 浙江普洛家园药业有限公司 | 2-羟基-5-[2-(4-(三氟甲基苯基)乙基氨基)]苯甲酸晶型及其制备方法 |
CN112409201B (zh) * | 2020-12-08 | 2022-10-25 | 浙江普洛家园药业有限公司 | 2-羟基-5-[2-(4-(三氟甲基苯基)乙基氨基)]苯甲酸的制备方法 |
Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR100852962B1 (ko) * | 2007-11-12 | 2008-08-20 | 주식회사 뉴로테크 | 2-하이드록시-5-페닐알킬아미노벤조산 유도체 및 이의 염의제조방법 |
KR20090007581A (ko) * | 2006-04-13 | 2009-01-19 | 주식회사 뉴로테크 | 세포 손상 및 염증 질환의 치료 또는 예방용 약학 조성물 |
WO2009045083A2 (en) * | 2007-10-05 | 2009-04-09 | S.H. Pharma., Ltd | Combination therapy for neuroprotection |
KR20090037715A (ko) * | 2007-10-12 | 2009-04-16 | 주식회사 뉴로테크 | 생체이용률이 개선된 약학 조성물 |
-
2009
- 2009-12-29 KR KR1020090132403A patent/KR101646701B1/ko active IP Right Grant
-
2010
- 2010-12-29 WO PCT/KR2010/009498 patent/WO2011081445A2/ko active Application Filing
Patent Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR20090007581A (ko) * | 2006-04-13 | 2009-01-19 | 주식회사 뉴로테크 | 세포 손상 및 염증 질환의 치료 또는 예방용 약학 조성물 |
WO2009045083A2 (en) * | 2007-10-05 | 2009-04-09 | S.H. Pharma., Ltd | Combination therapy for neuroprotection |
KR20090037715A (ko) * | 2007-10-12 | 2009-04-16 | 주식회사 뉴로테크 | 생체이용률이 개선된 약학 조성물 |
KR100852962B1 (ko) * | 2007-11-12 | 2008-08-20 | 주식회사 뉴로테크 | 2-하이드록시-5-페닐알킬아미노벤조산 유도체 및 이의 염의제조방법 |
Also Published As
Publication number | Publication date |
---|---|
KR101646701B1 (ko) | 2016-08-08 |
KR20110075842A (ko) | 2011-07-06 |
WO2011081445A2 (ko) | 2011-07-07 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
WO2014028589A3 (en) | 4-HETEROARYL SUBSTITUTED BENZOIC ACID COMPOUNDS AS RORgammaT INHIBITORS AND USES THEREOF | |
EP2340821A4 (en) | PROPHYLAXIS AGENTS / ADULTS OF ADULT DISEASES WITH 5-AMINOLEVULINIC ACID, A 5-AMINOLEVULIC ACID DERIVATIVE OR 5-AMINOLEVULIC ACID SALT OR 5-AMINOLEVULIC ACID DERIVATIVE AS AN ACTIVE SUBSTANCE | |
SMT201600055B (it) | Composizione farmaceutica per il trattamento o la prevenzione del glaucoma | |
EP2418200A4 (en) | PHTHALIAMIDE DERIVATIVES FROM NON-SERIOUS ANTI-INFLAMMATORY COMPOUNDS AND / OR TNF MODULATORS, METHOD OF MANUFACTURING THEREOF, PHARMACEUTICAL COMPOSITIONS THEREFOR AND THEIR USE FOR THE TREATMENT OF INFLAMMATORY DISEASES | |
WO2014028600A3 (en) | 3-AMINOCYCLOALKYL COMPOUNDS AS RORgammaT INHIBITORS AND USES THEREOF | |
HK1163500A1 (en) | Pharmaceutical composition for the treatment of heart diseases | |
CO6771409A2 (es) | Acidos 1-bencilcicloalquilcarboxilicos sustituidos y su uso | |
WO2011077043A3 (fr) | Derives phenoliques, et leur utilisation pharmaceutique ou cosmetique | |
WO2010128050A3 (en) | Dihydroorotate - dehydrogenasee inhibitors as virostatic compounds | |
WO2011012816A3 (fr) | Formulation pharmaceutique | |
WO2011014825A3 (en) | Antiangiogenic small molecules and methods of use | |
IL208357A0 (en) | Spiro-indole derivatives for the treatment of parasitic diseases | |
IL199829A0 (en) | Use of substituted pyranone acid derivatives for the treatment of metabolic syndrome | |
WO2010132347A9 (en) | Docosahexaenoic acid for the treatment of heart failure | |
WO2010150211A3 (en) | Use of derivatives of indoles for the treatment of cancer | |
WO2012037562A3 (en) | Pharmaceutical and nutraceutical compositions of abscisic acid | |
HK1144553A1 (en) | Use of an acetylsalicylic acid salt for the treatment of viral infections | |
WO2011006935A3 (en) | Tetrazole derivatives | |
EP2394645A4 (en) | MEDICAL USE OF 5-BENZYLAMINOSALICYLIC ACID DERIVATIVES OR SALTS THEREOF | |
EE201300004A (et) | Kombineeritud ravimkoostis sdame-veresoonkonnaga seotud haiguste v?i seisundite raviks | |
WO2010121675A3 (en) | Thiazolyl-benzimidazoles | |
UA109793C2 (uk) | Арилсульфонаміди для лікування захворювань центральної нервової системи (цнс) | |
WO2011081445A3 (ko) | 에틸아미노 벤조산 유도체의 치료 용도 | |
EP2157089A4 (en) | THERAPEUTIC USES OF IMIDAZOL-5-CARBOXYLIC ACID DERIVATIVES | |
WO2011002814A3 (en) | Sulfonamido - biphenyloxyacetic acid compounds |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
121 | Ep: the epo has been informed by wipo that ep was designated in this application |
Ref document number: 10841277 Country of ref document: EP Kind code of ref document: A1 |
|
NENP | Non-entry into the national phase |
Ref country code: DE |
|
122 | Ep: pct application non-entry in european phase |
Ref document number: 10841277 Country of ref document: EP Kind code of ref document: A2 |